# 16.0040 Ankylosing Spondylitis Study

> **NCT00356356** · PHASE3 · COMPLETED · sponsor: **Amgen** · enrollment: 257 (actual)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **DRUG:** Etanercept

## Key facts

- **NCT ID:** NCT00356356
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** 2006-08
- **Final completion:** 2006-09
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2013-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00356356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00356356, "16.0040 Ankylosing Spondylitis Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00356356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*